Wockhardt Extends Deadline to Use Rs 162 Crore QIP Funds to FY28

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Wockhardt Extends Deadline to Use Rs 162 Crore QIP Funds to FY28
Overview

Wockhardt Limited has extended the deadline to utilize the remaining Rs 162.33 crore from its Qualified Institutional Placement (QIP) proceeds to financial year 2028. The company cited ongoing business needs and project timelines for the extension. As of March 31, 2026, Rs 815.46 crore out of the Rs 977.79 crore net proceeds had been used.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Wockhardt Limited has given itself until financial year 2028 to spend the remaining funds from its recent Qualified Institutional Placement (QIP). The company stated that ongoing business needs and project timelines require the extended deadline.

Fund Utilization Update

As of March 31, 2026, Wockhardt had deployed Rs 815.46 crore of the Rs 977.79 crore in net proceeds from the QIP. This leaves Rs 162.33 crore still unutilized.

Fundraising Background

The pharmaceutical firm raised about Rs 1,000 crore through the QIP in November 2024. The original plan was to use these funds for clinical trials, research and development (R&D), and working capital for its operations.

Implications of the Extension

The extended timeline provides Wockhardt with more flexibility to allocate capital for its long-term projects. Investors will be monitoring the deployment of the remaining Rs 162.33 crore by the new March 2028 deadline. The company confirmed there have been no deviations from the planned uses of the funds.

Potential Hurdles

Challenges in project execution due to evolving business conditions could still affect the full utilization of the remaining capital.

What Investors Can Watch

Moving forward, investors will likely focus on how Wockhardt progresses with the deployment of the remaining QIP funds, any specific updates on the projects being financed, and the company's overall financial health and R&D advancements.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.